Background: Foxn1 D/D mutant mice have a specific defect in thymic development, characterized by a block in TEC differentiation at an intermediate progenitor stage, and blocks in thymocyte development at both the DN1 and DP cell stages, resulting in the production of abnormally functioning T cells that develop from an atypical progenitor population. In the current study, we tested the effects of these defects on thymic selection.
Introduction
The thymus is the primary site of T cell development. In the thymus, heterogeneous thymic epithelial cells (TECs) and other stromal cells including fibroblasts, dendritic cells, and macrophages constitute a 3-dimensional space that provides a unique microenvironment for the differentiation, proliferation, and maturation of T cells. During differentiation, T cells undergo VDJ recombination generating a diverse repertoire of TCRs. Thymic positive selection ensures the differentiation and maturation of thymocytes expressing a self-restricted TCR; negative selection then removes those thymoctyes that have dangerously high reactivity to self [1] . The resulting T cells migrate out of the thymus resulting in a diverse repertoire of T cells that are able to respond to foreign peptides while remaining tolerant to selfpeptides. The positive selection of CD4 and CD8 T cells is restricted by MHCII and MHCI respectively. The development of TCRab CD4 T cells can be typically supported by MHCII expressing TECs, while CD8 T cells can be supported by MHCI signals from TECs and other stromal cells in thymus [2, 3, 4, 5, 6] . The thymic medulla has been shown to be largely responsible for negative selection [7, 8] . In the cortico-medullary junction and medulla, dendritic cells (DCs) play a major role in negative selection; medullary TECs have also been reported to be sufficient to drive this process [9] .
The development, differentiation, and function of fetal TECs are controlled by the forkhead-class transcription factor Foxn1 [10, 11, 12, 13, 14] . Foxn1 is widely if not ubiquitously expressed in fetal TECs from a very early stage [13, 15] . In the absence of Foxn1 (i.e. in nude homozygotes), the thymic rudiment is formed, but lymphoid progenitor cells (LPCs) fail to populate it [12, 14, 16] . In a severe hypomorphic allele, Foxn1 D , initial organogenesis appears normal, but later thymocyte-dependent TEC differentiation is blocked [2] . Thus, Foxn1 is required for both thymocytedependent and -independent TEC differentiation. In the postnatal thymus, Foxn1 expression is distributed in both cortex and medulla [12, 17, 18] . We have recently reported that correct expression of Foxn1 is also required to maintain the postnatal thymus, as postnatal reduction of Foxn1 expression leads to a phenotype resembling premature thymic involution [18] . Down regulation of Foxn1 has also been implicated in initiating thymic involution [19] . Thus, Foxn1 plays multiple crucial roles in the development and maintenance of TECs throughout the lifespan of the organism.
Foxn1 D/D mice have a very small thymus with abnormal architecture lacking cortical and medullary domains, in which most TECs display an intermediate progenitor phenotype [10] . Thymocytes are specifically blocked at both the DN1 and DP differentiation stages, express constitutively low TCR, and very few SP thymocytes develop and immigrate into the periphery [10] . The resulting peripheral T cells have an atypical activated/ memory phenotype with low homeostatic potential and impaired TCR signaling [20] . T regulatory (T reg ) cells are generated but have reduced function, and T cells are hyper-responsive in both allo-and auto-MRL assays in vitro [21] . These abnormal T cells develop from CD117
2 atypical progenitors without passing through the DN2 or DN3 stages, but directly develop into DN4 from DN1 cells in the postnatal thymus [20] . As these atypical progenitors are normally present in the wild-type thymus, these may represent a normal sub-population of T cells that may serve a specific as yet unknown function in the normal T cell repertoire. As these T cells also have constitutively low TCR expression, the question of whether this abnormal microenvironment is promoting normal positive and negative selection is also important to understanding the mechanism by which these T cells are generated.
In the current study, we investigated the processes of positive and negative selection in Foxn1 D/D mutants. We show that TEC expression of both MHC Class I and II are reduced significantly, with MHC Class II expression affected more severely. We generated Foxn1 D/D BALB/c (MHCII I-E molecule positive) mice, and crossed Foxn1 D/D to the DO11.10 CD4 and OT1 CD8 restricted TCR transgenes. By focusing on the TCR Vb usage and the phenotypes of CD4 and CD8 Tg cells in the thymus or periphery of Foxn1 D/D mice, we analyzed the thymic negative and positive selection and assayed SP thymocyte post-selection maturation in the thymus. We also analyzed T cell responses to specific antigens in vivo. Our results show that the Foxn1 D/D thymus did not generally affect the diversity of the TCR Vb repertoire, although the frequencies of specific Vb usage were highly variable in the mutants compared to controls. However, thymic negative selection was partially reduced and positive selection was dramatically reduced for CD4 T cells, but relatively normal for CD8 T cells. These T cells generated abnormal responses to antigen-specific stimulation in vivo. At least part of this abnormal response was secondary to the previously reported memory-like phenotype of T cells after lymphopenia-induced proliferation and reduced T reg cell function in the Foxn1 D/D periphery [20] . Thus, the peripheral T cell phenotype in the Foxn1 D/D mutants is the result of both direct effects of abnormal selection within the thymus, compounded by secondary effects of low T cell output and a hypocellular peripheral environment.
Results

Peripheral T cells have broad but variable TCR Vb usage in Foxn1
D/D mutant mice
Our previous data reported that T cells in Foxn1 D/D thymus appear to develop from an atypical CD117 low/2 progenitor that develops directly from DN1-DN4 stages, but did undergo TCR VDJ recombination [20] . This result raises the question of whether this atypical pathway generates a diverse TCR repertoire. Because the number of SP thymocytes in the Foxn1 D/D thymus was too low to be analyzed directly for TCR Vb usage, we assayed TCR Vb expression on peripheral T cells (Fig. 1) . We found that all TCR Vb alleles were detected on both CD4 and CD8 Foxn1 Based on the expression of TCR Vb, we designed an experiment to test thymic negative selection. Endogenous superantigen-mediated TCR Vb T cell clonal deletion generally occurs in mice that express an endogenous super-antigen and the MHC-II I-E molecule [22] . The expression of Vb5.1 and Vb11 were clear on T cells in the Foxn1 D/D and Foxn1 +/D mice, both of which are maintained on the C57BL/6 background ( Fig. 2A) , because these mice failed to delete them due to lack of MHCII I-E molecules on TECs. In BALB/c mice, which express the MHCII I-E molecule, Vb5.1 and Vb11 bearing T cells are deleted ( Fig. 2A , B, D) [22] . We therefore backcrossed the C57BL/6 I-E (Fig. 3A, B) , with around 93% of CD4 + SP cells being Kj1-26 + transgene-expressing T cells (Fig. 3C ). The number of total thymocytes was also increased (Fig. 3D) D/D ;OT1 mice, the percentage of CD8 SP thymocyte was increased 3 fold (from 2.1% to 6.2%), and 81.9% CD8 SP thymocytes were CD8 Tg cells (Fig. 4A, B, C) . Compared to non-transgenic mice, the total thymic cell number was reduced in the Foxn1 +/D ;OT1 control mice, but was unchanged in Foxn1 D/D ;OT1 mice (Fig. 4D) . For peripheral T cell analysis, the results were similar to thymus, except there was no significant difference in total cell number between mice of different genotypes (Fig. 4E, F 
Maturation of SP thymocytes was delayed in Foxn1
D/D mice and immature SP thymocytes migrate into the periphery
In the postnatal thymus, SP thymocytes stay in the thymic medulla after positive selection for 3 to 5 days for further maturation [24, 25] . We previously reported that the thymic architecture was completely disorganized in the Foxn1 D/D mice, with lack of cortico-medullary junction and medullary organiza- Impaired Thymic Selection in Foxn1tion, as well as decreased TEC differentiation [10] , although SP thymocytes do leave the thymus and colonize the periphery [20] . This raises the question of whether and how SP thymocytes undergo maturation in this deficient environment. To address this issue, we assayed expression of the maturation markers HSA and Qa2 on adult peripheral T cells. As we have previously shown that SP thymocytes in the Impaired Thymic Selection in Foxn1 In control mice at the newborn stage, most CD4 and CD8 SP thymocytes are HSA hi , while in the spleen the vast majority of T cells have down regulated HSA, and there is essentially no Qa2 expression in either population (Fig. 6A) . By Day 14, over half of SP thymocytes have down regulated HSA, and a few also have low levels of Qa2. In contrast, over 50% of CD4 and over 80% of CD8 splenic T cells are Qa2
+ , and virtually all are HSA negative (Fig. 6B) D/D T cells had constitutively high expression of CD44, so this was not a reliable marker for activation status [21] (Fig. 6D) .
CD8 T cells have different responses to SEA super-antigen in vivo
We next assayed how these T cells responded to specific antigen in the periphery. We first tested the response of TCR Vb T cell clones to the super-antigen SEA in vivo. Before and after exposure to SEA, the expression of Vb3 and Vb11 were measured in individual mice. Because the frequency of Vb3 and Vb11 bearing cells in individual Foxn1 D/D mice was quite variable, the percentage change in Vb3/11 bearing cells in individual mice was shown by the ratio of before and after injection. As expected, the percentage of Vb3/11 bearing CD4 and CD8 T cells increased 2-4 fold after exposure to SEA at day 2 post-injection in the Foxn1 +/D mice, and then went down rapidly to the same or even below the level seen before exposure (Fig. 7) , similar to a previous report [20] . However in the Foxn1 D/D mice, the Vb3-bearing CD4 T cells showed a delayed but a stronger and longer lasting response, with a 5-fold increase in percentage at day 6 after SEA exposure, and then a slow decline. CD8 T cells also had a delayed response although it was weaker than CD4 T cells, and even weaker than Foxn1 +/D CD8 T cells (Fig. 7A ). Both Foxn1
Vb11 bearing CD4 and CD8 cells had a delayed and weaker response to SEA compared to the same cells in the Foxn1 +/D mice (Fig. 7B ). These data indicated that different Foxn1 D/D T cell clones have different responses to the same antigen in vivo. Thus, some clones might increase and some clones might be reduced in response to the same antigen.
The thymus defects in the Foxn1 D/D mice result in very low SP cell production and decreased T cell output from the thymus, causing a hypocellular peripheral environment [10, 20] . The hypocellular periphery contributes to the peripheral T cell phenotypes by promoting an activated/memory phenotype in most T cells [20] . To distinguish whether the abnormal response of Foxn1 D/D T cells was directly due to the developmental defect in the thymus or the environmental defect in periphery, 4610 6 sorted Ly5.1 wild-type peripheral T cells per mouse were retroorbitally transferred into Foxn1 D/D adult mice. One day later, 1 mg SEA per mouse was injected. The percentages of Vb3 bearing T cells of both host and donator were measured before and after injection of SEA and shown as the ratio of percentage (Fig. 7B) . After 2 days of exposure to SEA, the percentage of transferred Ly5.1 Vb3 bearing wild-type CD4 cells was increased more than 2 fold, which reached a peak of 8 fold at day 4 and then reduced. A similar result was showed in Ly5.1 wild-type CD8 cells. The percentages of transferred Vb3 bearing CD4 and CD8 clones did not increase in the absence of SEA injection, indicating that the increase in transferred Vb3 bearing CD4 and CD8 clones was not due to homeostatic proliferation. These results suggest that the hypocellular peripheral environment shapes the response of T cells to specific antigen. The host Vb3 bearing CD4 cells had a weaker response to SEA than transferred Ly5.1 wild-type cells, although the magnitude of their response was similar to that seen in panels A and B. This suggests that in direct comparison to wild-type cells, the of Tg CD8 population in percentage, and 2 mg OVA gave a 1.3 fold increase. Doses of OVA below 2 mg caused a decrease in the percentage of CD8 + ;OT1 Tg cells (Fig. 8A) , as previously reported [26, 27] . In the Foxn1 D/D ;OT1 Tg mice, a hypersensitive response was seen in the CD8 + ;OT1 Tg population. Doses of 0.5 mg were enough to drive a dramatic expansion of CD8 + ;OT1 Tg cells at day 2 to a level higher than that seen with the 20 mg dose in
Foxn1
+/D ;OT1 Tg control mice. This response lasted 2 days longer than the response in Foxn1 +/D ;OT1 Tg control mice, then fell to the level of day 0 at day 6. At no dose did the CD8 + ;OT1 Tg population significantly decrease to below the level of day 0 in Foxn1 D/D mice (Fig. 8B) . Thus, the Foxn1
D/D
;OT1 Tg T cells had a hypersensitive proliferative response to low doses of antigen, and never responded to antigen by with clonal deletion. Fig. 8C-E) . Two days later (Day 0) we injected a low dose of OVA at 0.25 mg per mouse. As above, the percentage of CD8 + ;OT1 Tg cells was measured before and after injection of OVA, and the change of percentage of CD8 + ;OT1 Tg cells was shown as a ratio. As expected, host T cells showed no change either in the presence or absence of OVA over a 12-day period (Fig. 8C) . The percentage of transferred CD8
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+ ;OT1 Tg cells increased at day 2 after injection of OVA, and then reached a peak to 8 fold higher than the level of day 0, consistent with an LIP response in the hypocellular Foxn1 D/D peripheral environment [20] . In recipient mice that were given injection of OVA, the percentage of CD8 + ;OT1 Tg cells increased more slowly and reached a lower peak (3 fold increase) than with cell transfer alone. Our interpretation of this result is that the expansion of CD8 + ;OT1 Tg cells was driven by LIP, and that the low dose of 0.25 mg OVA induced some level of clonal deletion in the CD8 + ;OT1 Tg, as it did in the Foxn1 +/D ;OT1 Tg mice (Fig. 8A) . If the OVA had further stimulated the LIP effect, the percentage of CD8
+ ;OT1 Tg cell should have been higher than the percentage in the cell transfer control group (Fig. 8C ). Thus, with OVA challenge immediately after cell transfer, the transferred CD8 + ;OT1 Tg cells underwent clonal deletion in response to the i.v. injection of OVA.
The possibility that we were inducing simultaneous LIP and clonal deletion in the above experiment raised the issue of whether we could separate the two responses. Another experiment was performed which OVA was injected 12 days after CD8 + ;OT1 Tg cells were transferred. At this time, all the transferred CD8 + ;OT1 Tg cells had already undergone LIP, and displayed a proliferating status and were CD44 hi , but the percentage had returned to a level similar to day 0 (Fig. 8C and data not shown) . This situation was therefore more similar to that of the host T cells in the Foxn1 [20] . In controls that received cells only, the percentage of CD8 + ;OT1 Tg cells did not change over the additional 12-day period without OVA injection ( Figure 8D ). In contrast, after injection of OVA the percentage of CD8 + ;OT1 Tg cells increased 2 days later, with a overall profile similar to that seen with injection of OVA soon after cell transfer ( Figure 8C ), rather than undergoing deletion as seen in the Foxn1 +/D ;OT1 Tg mice. This result indicated that he response to OVA was dictated not by the thymic environment in which they developed, but by the peripheral environment in which they were exposed to OVA. We interpret this result to mean that exposure to the lymphopenic peripheral environment of the Foxn1 D/D mice and subsequent LIPinduced development of a CD44 hi memory like phenotype conferred to the transferred cells a hypersensitive response to specific antigen. Figure 8E with 8B). In the OVA plus Treg group, the percentages of Tg CD8 cells were decreased comparing to the percentage in OVA non-Treg cells group (Fig. 8E) 
Discussion
Our previous work has shown that the thymic microenvironmental defects in the Foxn1 D/D mouse result in a variety of secondary effects on thymocyte development and peripheral T cell function [10, 20, 21] . The primary result from these previous studies was that T cells in the Foxn1 D/D thymus developed from kit negative progenitor cells via an atypical differentiation pathway. Our current data further explore the mechanisms by which this defective microenvironment influences thymocyte development, specifically positive and negative selection, and how these defects impact T cell function. We show that these atypical T cells have surprisingly normal Vb usage, but significant defects in positive and negative selection, especially for CD4 + SP cells. Furthermore, immature SP cells were able to exit the thymus prematurely. These defects were exacerbated by peripheral lymphopenia caused by the low thymic output, and the poor function of T reg cells generated in the Foxn1 D/D mice. Thus, peripheral T cell phenotypes were due to both primary defects in the thymic Canonical TCRab progenitors perform VDJ recombination randomly after commitment, but positive selection for different Vb may need continuous development of a variety of TECs [5] . In spite of the severe defects in Foxn1 D/D TEC differentiation and the lack of organized thymic compartments, we found that Vb usage on peripheral T cells was largely similar to control mice. This result suggested that these atypical progenitors had relatively normal VDJ recombination of TCR Vb, that the severe TEC defect in the Foxn1 D/D thymus did not significantly affect the ability to support the process of TCRab commitment, and that there was Impaired Thymic Selection in Foxn1no selective loss of specific Vb bearing clones during positive selection. However, the peripheral Vb repertoire was highly variable between mice. This variability could reflect variability in the differentiation and/or organization of the thymic environment between different mutant mice. Alternatively, T cells with higher affinity to MHC may undergo selective expansion via homeostatic induced proliferation in the Foxn1 D/D lymphopenic periphery, where MHCII expression should be normal. In the case of TCR Vb5, this allele was reported to advantageously expand in inflammatory bowl disease (IBD) [28, 29] . As our previous data also showed that some Foxn1 D/D mice showed autoimmune disease symptoms including prolapse [20] , the increased TCR Vb5 expression in the Foxn1 D/D periphery might be driven by an autoimmune response.
While DCs are the major stromal cells that perform negative selection at the cortical-medullary junction (CMJ) and in the medulla, TECs can also contribute to this process [9] . In this study, although the percentage of bone marrow derived DCs in the Foxn1 D/D thymus was relatively increased, the capability of negative selection was still lower in the mice compared to in the Foxn1 +/D mice. This reduction of negative selection may be due to the abnormal thymic architecture, with lack of both CMJ and medulla in the Foxn1 D/D thymus, making it difficult for the SP thymocytes to interact properly with DCs. In addition, the reduction in negative selection could be secondary to premature exit of immature T cells from the thymus. In the normal thymus, SP thymocytes undergo maturation in the medulla for 10-14 days, during which time the expression level of HSA is down-regulated, and Qa2 is gradually up-regulated [24, 30, 31] + T cells appeared more normal than CD4 T cells (Fig. 5D ). Other work in our lab has shown that the thymic vasculature in Positive selection of CD4 TCRab thymocytes is completely dependent on MHC II expressing TEC, while the development of CD8 thymocytes can be supported by MHC I on both TEC and other thymic stromal cells in thymus [32, 33, 34] . In Foxn1 D/D thymus, the positive selection for CD4 transgenic T cells was dramatically damaged, while the selection for CD8 transgenic T cells was less affected (Fig. 3, 4) . This difference between CD4 and CD8 is consistent with the greatly reduced expression of MHC II on TECs, while MHC I was almost normal in the Foxn1 D/D thymus [10] , (Fig. 5) . This result was also consistent with our data from another Foxn1 mutant, Foxn lacz , in which Foxn1 expression is gradually down-regulated after birth. In these mice, MHC II expression on TECs and production of CD4 T cells was reduced, but CD8 T cells appeared normal [18] . The CD1 molecule was reported to support CD4 positive selection in MHC II 2/2 mice [35] . CD1 expression was normal in Foxn1 D/D thymus (data not shown), suggesting that it might support some positive selection for CD4 T cells in Foxn1 D/D mice. Alternatively, the reduced positive selection could be due in part to an inability of the thymocytes themselves to respond to selection signals, either due to prior developmental deficits, or to intrinsic qualities based on their differentiation from an atypical progenitor cell [20] .
These intrathymic defects in T cell differentiation and selection gave rise to peripheral T cells with defects in in vivo antigen-specific response. The antigen-specific response in vivo is a complicated process. Multiple facts may affect the process such as the dose of antigen, preparation of antigen, usage of adjuvant, the way of giving antigen, animal age and immune status [26, 27, 36, 37, 38, 39] . For example, oral feeding of antigen may result in tolerance through anergy [39] ; intravenous injection of antigen may delete antigen specific T cells rapidly, with remaining cells hyporesponsive; while the subcutaneous injection of antigen may delete antigen specific T cells, with the remain cells hypersensitive [36] . Both low and high dose antigen can result in tolerance, but low dose of antigen results in anergy or clone deletion, while high dose of antigen results in active suppression of antigen specific T cells [26, 27] . During antigen specific tolerance, the CD25 + CD4 + T regulatory cells that develop in the thymus play an important role in the process of tolerance and immune balance [38, 40] . In Foxn1 D/D mice, the peripheral T cells had an abnormal response to specific antigens; CD4 T cells showed a delayed and strong response to SEA, while CD8 T cells had a delayed but weaker response compared to the same cells in the Foxn1 +/D mice (Fig. 7) , or to that reported in wild-type mice [41] . Both intrathymic and peripheral defects could contribute to the abnormal antigen response of Foxn1 D/D T cells: 1) the deficient thymic environment, including the down-regulation of MHC II on TEC, might preferentially select the higher avidity T cells, and these cells could not be deleted by negative selection; 2) the abnormally lymphopenic peripheral environment causes lymphopenia induced proliferation (LIP) [20] ; this could cause some clones with a higher avidity to be advantageously expanded in the (Fig. 7) implicates the peripheral environment, rather than the development in an abnormal thymic microenvironment, in this abnormal response. Furthermore, we showed that wild-type CD4 + CD25 + regulatory T cells transferred into Foxn1 D/D mice could partially inhibit the strong response (Fig. 8E) 
Materials and Methods
Mice and treatment
Foxn1
D/D mutant mice generated in our laboratory were described previously [10] . The mice were of a mixed C57BL/6J and 129SvJ background. BL/6-Ly5.1 mice, BALB/c mice, DO11.10 and OT1 TCR-transgenic mice were obtained from 
Flow Cytometry Analysis and Antibodies
Splenocyte and thymocyte cell suspensions were prepared and counted for total cell numbers. Blood samples were taken by retroorbital bleed on the indicated day; 50-100 ml blood was collected and blood mononuclear cells were isolated by density gradient centrifugation and lysis of RBC. All blood mononuclear cells and 0.5-1610 6 thymocytes or splenocytes were stained with the following mAbs conjugated to PE, FITC, allophycocyanin directly, or Biotin-labeled mAbs, followed by Strepavidin-PerCP: Mouse TCR Vb screening panel, anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD3e (145-2c11), anti-HSA (M1/69), and anti-Qa2 (H-2), anti-Kj1-26, anti-Vb3 (Kj25), anti-Vb5.1,5.2 (MR9-4), anti-Vb11 (RR3-15), and antiVa2 (B20.1) anti-CD44 (IM7), anti-CD25 (7D4), anti-CD69 (H1.2F3), (all Abs from BD Pharmingen, San Diego, CA).
For the staining of MHCI and MHCII on CD45 -thymic stromal cells (TSC), thymic lobes were cut and washed in RPMI 1640+2%FBS medium to deplete most thymocytes, thymic fragments were then digested by collagenase/dispase (1 mg/ml, Roche Applied Science) plus DNase I (5 mg/ml) in RPMI 1640 plus 2%FBS medium for 1-1.5 hours at 37uC bath. The enriched TSCs were then stained with anti-CD45-allophycocyamin (30-F11), anti-MHCI H-2Kb PE (AF6-88.5), and MHCII I-A/I-E FITC (M5/114.15.2) (Biolegend). Anti-CD16/32 (2.4G2) (Biolegend or BD Pharmingen) and Rat-serum were used to block FCreceptors before staining. Three-or four-color immunofluorescence analysis was performed using a FACSCalibur system. The data were analyzed using CellQuest software (Becton Dickson, Franklin Lake, NJ).
Activation of peripheral T cells by anti-CD3 antibody in vitro
26106 peripheral lymphocytes prepared from spleen and LNs were plated in 24-well plates previously coated with 10 mg/ml of anti-CD3e Ab and cultured for 24 h. As a control, cells were cultured in media alone. Cells were harvested after 9 and 24 hour culture and stained with anti-CD4, anti-CD8, and anti-CD44, anti-25 and anti-CD69 markers, then placed in FACS store solution for analysis by flow cytometry.
Adoptive transfer
Peripheral lymphocyte suspensions were prepared from freshly isolated spleen and lymph nodes from C57BL6/J Ly5. 1 
